Kappa Opioid Receptor Ligands and Pharmacology: Diphenethylamines, a Class of Structurally Distinct, Selective Kappa Opioid Ligands | SpringerLink
CR845 (Difelikefalin), A Kappa Receptors Agonist In Phase III By CARA Therapeutics: A Case Of 'Spin' In Scientific Writing? | Semantic Scholar
Cara Therapeutics: Scratching An Itch Left Unscratched (NASDAQ:CARA) | Seeking Alpha
Role of kappa‐opioid and mu‐opioid receptors in pruritus: Peripheral and central itch circuits - Kim - 2022 - Experimental Dermatology - Wiley Online Library
Peptide Kappa Opioid Receptor Ligands and Their Potential for Drug Development | SpringerLink
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
Strategies for Developing κ Opioid Receptor Agonists for the Treatment of Pain with Fewer Side Effects | Journal of Pharmacology and Experimental Therapeutics
Design of a Stable Cyclic Peptide Analgesic Derived from Sunflower Seeds that Targets the κ-Opioid Receptor for the Treatment of Chronic Abdominal Pain | Journal of Medicinal Chemistry
PDF) In Vitro, In Vivo and In Silico Characterization of a Novel Kappa- Opioid Receptor Antagonist
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
Titan Pharmaceuticals, UW treating chronic itch with ProNeura implant - BioTuesdays
Will peripherally restricted kappa‐opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential? - Albert‐Vartanian - 2016 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
Kappa opioid receptor binding affinity and the effects on... | Download Scientific Diagram
Peptide Kappa Opioid Receptor Ligands and Their Potential for Drug Development | SpringerLink
Design of a Stable Cyclic Peptide Analgesic Derived from Sunflower Seeds that Targets the κ-Opioid Receptor for the Treatment of Chronic Abdominal Pain | Journal of Medicinal Chemistry
A Systematic Review on the Kappa Opioid Receptor and Its Ligands: New Directions for the Treatment of Pain, Anxiety, Depression,
5 Promising Companies In The Non-Opioid Drug Industry | Avise Analytics
Articles about Cara Therapeutics, Inc. | page 3
Experimental Kappa Opioid Appears Safe and Effective
Kappa opioid receptor binding affinity and the effects on... | Download Scientific Diagram
Peripheral kappa opioid receptor activation drives cold hypersensitivity in mice | bioRxiv
Cara Therapeutics: Scratching An Itch Left Unscratched (NASDAQ:CARA) | Seeking Alpha
Nephrology Journal Club on X: "Difelikefalin (CR845) (KORSUVA) is a peripherally restricted, selective kappa opioid receptor agonist that exerts antipruritic effects by means of activation of kappa opioid receptors on peripheral neurons
